Pediatric Formulation of the Pfizer COVID-19 Vaccine Pending Approval by WHO team

By Aaron Humes: In an update to a story last week, the Caribbean Public Health Agency (CARPHA) reports that while the World Health Organization (WHO)’s Strategic Group of Experts (SAGE) that advises on Immunization has recommended the use of the vaccine in children 5-11 years of age, it is not yet listed for emergency use.

Approval for that comes from the WHO’s Emergency Use Listing Prequalification Team.

The Prequalification Team looks at all aspects of the vaccine including composition, creation; dispensation; packaging, and storage, all critical to ensuring the efficacy of the final vaccine product to be used on children.

CARPHA recognizes the WHO EUL procedure and collaborates with WHO Prequalification team to develop summaries and recommendations for vaccines listed under the EUL.

This is consistent with public presentations made by Dr. Joy St. John, the Executive Director of CARPHA, and Dr Rian Extavour, Programme Manager, CARPHA Caribbean Regulatory System (CARPHA-CRS).

In that regard, at this time, CARPHA-CRS has not yet recommended the pediatric formulation due to the absence of confirmation of the new formulation by the World Health Organization (WHO) Prequalification team under the relevant Emergency Use Listing (EUL).

Adults and children between 12 and 17 are clear to use the vaccine, created by Pfizer.

Advertise with the mоѕt vіѕіtеd nеwѕ ѕіtе іn Belize ~ We offer fully customizable and flexible digital marketing packages. Your content is delivered instantly to thousands of users in Belize and abroad! Contact us at mаrkеtіng@brеаkіngbеlіzеnеwѕ.соm or call us at 501-612-0315.

© 2022, BreakingBelizeNews.com. Content is copyrighted and requires written permission for reprinting in online or print media. Theft of content without permission/payment is punishable by law.